Yolk sac tumour in pre-pubertal girl: a case report
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20231947Keywords:
Ovarian tumour, Yolk sac tumour, Germ cells tumour, Surgical management, ChemotherapyAbstract
The commonest malignant ovarian tumour in the adolescent group is yolk sac tumour. It is commonly encountered in adolescents and young women. Incidence is 1% of all ovarian tumours. We reported a case of yolk sac tumour in a 9-year-old girl who presented with intermittent lower abdominal pain, not settling with medical management. Abdominal ultrasonogram showed a left adnexal echogenic mass measuring 5×6 cm with cystic spaces and internal vascularity. MRI abdomen showed T2/STIR hetero intense mass indenting the uterus and posterior bladder wall, multiple bilateral internal iliac, external iliac, left common iliac, aortic and bilateral inguinal nodes along with minimal ascites were seen. She underwent laparoscopy with trucut biopsy which showed moderate nuclear atypia with occasional Schiller-Duval body. Medical oncologist opinion was obtained and she was advised 4 cycles of chemotherapy with carboplatin, bleomycin and etoposide. Later she was planned for laparoscopic cytoreductive surgery. Laparoscopy showed rudimentary uterus, residual left ovarian mass, bilateral normal tubes and small pre-pubertal right ovary. Hence, left salpingo-oophorectomy, infra colic omentectomy and suspicious residual deposits of 1×1 cm near the right broad ligament were removed. Histopathological report of ovary showed no evidence of any residual malignancy. Peritoneum and omentum were free of tumour. Following laparoscopic cytoreductive surgery she is on follow up with AFP till date which is in declining levels and almost reached a normal value.
References
Arumugam D, Thandavarayan P, Chidambaram L, Boj S, Marudasalam S. Primary nasopharngeal yolk sac tumor: a case report. J Clin Diagnost Res. 2016;10(5):06.
Stang A, Trabert B, Wentzensen N, Cook MB, Rusner C, Oosterhuis JW, et al. Gonadal and extragonadal germ cell tumours in the United States, 1973–2007. Int J Androl. 2012;35(4):616-25.
Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY, et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107:1075.
Dallenbach P, Bonnefoi H, Pelte MF, Vlastos G. Yolk sac tumours of the ovary: an update. Eur J Surg Oncol. 2006;32:1063.
Guida M, Pignata S, Palumbo AR, Miele G, Marra ML, Visconti F, et al. Laparoscopic treatment of a yolk sac tumour: case report and literature review. Translational Med. 2013;7:1.
Shah JP, Kumar S, Bryant CS, Ali-Fehmi R, Malone JM, Deppe G, et al. A population-based analysis of 788 cases of yolk sac tumors: A comparison of males and females. Int J Cancer. 2008;123:2671.
Kojimahara A, Nakahar K, Takano T, Yaegashi N, Nishiyama H, Fujimori K, et al. Yolk sac tumor of the Ovary: A retrospective multicenter study of 33 Japanese women by Tohoku Gynaecologic Cancer Unit (TGCU). Tohoku J Exp Med. 2013;210:211-7.
Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst. 1983;71(6):1151-5.
Yamaoka T, Togashi K, Koyama T. Yolk sac tumor of the ovary: radiologic-pathologic correlation in four cases. J Comput Assist Tomogr. 2000;24(4):605-9.
Brammer HM, Buck JL, Hayes WS, Sheth S, Tavassoli FA. From the archives of the AFIP. Malignant germ cell tumors of the ovary: radiologic-pathologic correlation. Radiographics. 1990;10(4):715-24.
Mitchell PL, Al-Nasiri N, A’Hern R. Treatment of non-dysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer. 1999;85(10):2232-44.
Nawa A, Obata N, Kikkawa F. Prognostic factors of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol. 2001;184(6):1182-8.
Ishiguro T, Yoshida Y, Tenzaki T, Ohshima M, Suzuki H. AFP in yolk sac tumor and solid teratoma of the ovary: significance of postoperative serum AFP. Cancer. 1981;48(11):2480-4.
Davidoff AM, Hebra A, Bunin N, Shochat SJ, Schnaufer L. Endodermal sinus tumor in children. J Pediatr Surg. 1996;31(8):1075-8.
Teilum G. Endodermal sinus tumors of the ovary and testis. Comparative morphogenesis of the so-called mesonephroma ovarii (Schiller) and extraembryonic (yolk sac-allantoic) structures of the rat’s placenta. Cancer. 1959;12:1092-105.
Morimoto N, Ozawa M, Amano S. Diagnostic value of hyaline globules in endodermal sinus tumor: report of two cases. Acta Cytol. 1981;25(4):417-20.
Khoo SK, Buntine DW, Massey PF, Jones IS. Endodermal sinus tumour of the ovary: the place of alphafetoprotein detection, surgery and chemotherapy. Aust N Z J Obstet Gynaecol. 1981;21(4):217-25.
Moniaga NC, Randall LM. Malignant mixed ovarian germ cell tumour with embryonal component. J Pediatr Adolesc Gynecol. 2011;24:1.
Benedet JL, Bender H, Jones H, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000;70(2):209-62.
Nishio S, Ushijima K, Fukui A. Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary. J Obstet Gynaecol Res. 2006;32:416.
Gershenson DM. Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gynecol Oncol. 1994;55:62-72.
Fujita M, Inoue M, Tanizawa O, Minagawa J, Yamada T, Tani T. Retrospective review of 41 patients with endodermal sinus tumour of the ovary. Int J Gynaecol Cancer. 1993;3(5):329-35.
